Indaptus Therapeutics
INDP
6 hedge funds and large institutions have $12.9M invested in Indaptus Therapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
27% more capital invested
Capital invested by funds: $10.2M → $12.9M (+$2.72M)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$1.99M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$117K |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$44.9K |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$44.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$795K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $3.72M | +$44.9K | +5 | +1% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $3.35M | +$117K | +13 | +4% |
|
|
OM
3
Opaleye Management
Boston,
Massachusetts
| $2.99M | +$44.9K | +5 | +2% |
|
|
MIFH
4
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| $2.28M | +$1.99M | +221 | New |
|
|
DCM
5
DAFNA Capital Management
Los Angeles,
California
| $549K | – | – | – |
|
6
UBS Group
Zurich,
Switzerland
| $11K | – | – | – |
|
|
PA
7
Perceptive Advisors
New York
| – | -$795K | -86 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$3K | – | – |
|
INDP Hedge Fund Activity: Q2 2016 in Review
6 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q2 2016, worth a combined $12.9M — up 27% from $10.2M a quarter earlier.
Fund positioning in INDP was balanced in Q2 2016: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Migdal Insurance & Financial Holdings, opening a new position worth an estimated $1.99M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $795K sold.
- 6 institutional investors held Indaptus Therapeutics (INDP) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $12.9M of Indaptus Therapeutics stock for Q2 2016, up 27% quarter-over-quarter.
- 1 fund opened new Indaptus Therapeutics positions in Q2 2016 and 1 closed out, a net change of 0 holders.
- The largest Indaptus Therapeutics buyer in Q2 2016 was Migdal Insurance & Financial Holdings, an estimated $1.99M added.
- The largest Indaptus Therapeutics seller in Q2 2016 was Perceptive Advisors, an estimated $795K sold.
Based on aggregated 13F filings for Q2 2016.